FIELD: biotechnology.
SUBSTANCE: described is an agent containing Fc fragments of immunoglobulin G for treating autoimmune gastritis. Agent has a pronounced effect of suppressing an autoimmune reaction to parietal cells, an effect of suppressing inflammation and an effect of preventing destruction of parietal cells of the gastric mucosa.
EFFECT: wider range of products for treating autoimmune gastritis.
1 cl, 3 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF Fc-FRAGMENTS OF IMMUNOGLOBULIN CLASS G AS ANTIGEN FOR TREATING RHEUMATOID ARTHRITIS, REMEDY AND METHOD OF TREATING | 2008 |
|
RU2385164C1 |
| METHODS AND PRODUCTS FOR DIAGNOSTICS OF AUTOIMMUNE DISEASES AND GASTRIC CANCER, ASSOCIATED WITH ATROPHIC GASTRITIS | 2008 |
|
RU2519646C2 |
| AUTOIMMUNE GASTRITIS PATHOANATOMICAL DIAGNOSTICS METHOD | 2023 |
|
RU2819067C1 |
| Fc RECEPTOR BINDING AGENTS BASED ON INVARIABLE REGION OF IMMUNOGLOBULIN | 2008 |
|
RU2549676C2 |
| METHOD OF INDUCTION OF PROTECTIVE IMMUNE RESPONSE IN MAMMALS TO HELICOBACTER INFECTION, VACCINE FOR INDUCTION OF PROTECTIVE IMMUNE RESPONSE IN MAMMALS FOR HELICOBACTER INFECTION, METHOD OF INDUCTION OF PASSIVE PROTECTION IN MAMMALS AGAINST INFECTION WITH HELICOBACTER, AND METHOD OF ESTIMATION OF ENDOGENOUS IMMUNE RESPONSE IN MAMMALS INFECTED WITH HELICOBACTER | 1993 |
|
RU2125891C1 |
| PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE TREATMENT | 2000 |
|
RU2203682C2 |
| TACI-Fc FUSION PROTEIN AND ITS USE | 2019 |
|
RU2814988C2 |
| METHOD FOR DETECTING ANTIBODIES IN BLOOD SERUM ASSOCIATED WITH AUTOIMMUNE ENDOCRINE AND COMORBID PATHOLOGIES ON HYDROGEL BIOCHIP | 2022 |
|
RU2816512C1 |
| AGENTS FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASES | 2002 |
|
RU2281118C2 |
| LIPOSOMES CONTAINING OLIGOPEPTIDES - FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2009 |
|
RU2448685C2 |
